SEC Form 4 · accession 0001140361-16-060926
Spyre Therapeutics, Inc. · SYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell J. Cox
Director
Period of report
Apr 12, 2016
Accepted (ET)
Apr 12, 2016 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636282
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 12, 2016 | P | 7,000 | $10.00 | A | 7,000 | D |
Table II — derivative securities
No Table II lines on this filing.